JOHNSON & JOHNSON Item 5.07 Submission of Matters to a Vote of Security Holders.
(a) The 2021 Annual Meeting of Shareholders was held on
(b) At the 2021 Annual Meeting of Shareholders, the shareholders:
•elected all 14 Director nominees named in the 2021 Proxy Statement to the Company's Board of Directors;
•approved, on an advisory basis, the executive compensation philosophy, policies and procedures described in the "Compensation Discussion and Analysis" section of the 2021 proxy statement and the compensation of the Company's executive officers named in the 2021 Proxy Statement, as disclosed therein;
•ratified the appointment of
•did not approve the shareholder proposal for a report on government financial support and access to COVID-19 vaccines and therapeutics;
•did not approve the shareholder proposal for an independent board chair;
•did not approve the shareholder proposal for a civil rights audit; and
•did not approve the shareholder proposal for executive compensation bonus deferral.
The following are the final voting results for each of the seven items voted on
at the meeting.
1. Election of Directors:
Shares For Shares Against Shares Abstain Non-Votes
M. C. Beckerle 1,810,423,629 16,477,577 4,324,787 361,631,706
D. S. Davis 1,760,086,673 65,980,033 5,159,287 361,631,706
I. E. L. Davis 1,788,731,967 37,515,980 4,978,046 361,631,706
J. A. Doudna 1,814,385,723 12,552,555 4,287,715 361,631,706
A. Gorsky 1,699,594,759 119,253,059 12,378,175 361,631,706
M. A. Hewson 1,777,336,871 49,480,838 4,408,284 361,631,706
H. Joly 1,775,886,493 50,205,313 5,134,187 361,631,706
M. B. McClellan 1,808,590,798 17,138,760 5,496,435 361,631,706
A. M. Mulcahy 1,614,611,649 195,380,452 21,233,892 361,631,706
C. Prince 1,649,989,314 176,521,719 4,714,960 361,631,706
A. E. Washington 1,773,129,639 53,253,564 4,842,790 361,631,706
M. A. Weinberger 1,809,184,712 16,475,730 5,565,551 361,631,706
N. Y. West 1,817,859,141 8,942,629 4,424,223 361,631,706
R. A. Williams 1,749,060,576 77,138,736 5,026,681 361,631,706
2. Advisory Vote to Approve Named Executive Officer Compensation:
For 986,844,148
Against 753,486,152
Abstain 90,895,693
Non-Votes 361,631,706
--------------------------------------------------------------------------------
3. Ratification of Appointment of
For 2,080,036,325
Against 108,538,970
Abstain 4,282,404
Non-Votes N/A
4. Shareholder Proposal - Report on Government Financial Support and Access to COVID-19 Vaccines and Therapeutics:
For 573,465,487
Against 1,231,071,897
Abstain 26,688,609
Non-Votes 361,631,706
5. Shareholder Proposal - Independent Board Chair:
For 789,938,907
Against 1,032,409,877
Abstain 8,877,209
Non-Votes 361,631,706
6. Shareholder Proposal - Civil Rights Audit:
For 611,417,042
Against 1,192,232,580
Abstain 27,576,371
Non-Votes 361,631,706
7. Shareholder Proposal - Executive Compensation Bonus Deferral
For 410,065,480
Against 1,406,949,986
Abstain 14,210,527
Non-Votes 361,631,706
--------------------------------------------------------------------------------
© Edgar Online, source
